Current Research Studies

Humoral Immunity after CAR-T Cell Immunotherapy

FH10080

Condition(s): Other

What is the goal of the study?

This study will collect blood samples from patients who have had or who are having CAR-T cell treatment for any diagnosis. Samples will be tested to determine seroprotection for standard vaccine-preventable infections after CAR-T cell treatment, and to assess immune responses to vaccines after CAR-T cell immunotherapy.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Joshua Hill
Study Team Member: Jeanette Nguyen, Jeanette.Nguyen@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.